Petra Mrozkova Selected Research

N- (3- methoxyphenyl)- 4- chlorocinnamanilide

1/2021	Spinal PAR2 Activation Contributes to Hypersensitivity Induced by Peripheral Inflammation in Rats.
1/2018	Peripheral inflammation affects modulation of nociceptive synaptic transmission in the spinal cord induced by N-arachidonoylphosphatidylethanolamine.
1/2016	Hypersensitivity Induced by Activation of Spinal Cord PAR2 Receptors Is Partially Mediated by TRPV1 Receptors.
6/2014	TRPV1 receptor inhibition decreases CCL2-induced hyperalgesia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Petra Mrozkova Research Topics

Disease

4	Hyperalgesia 12/2021 - 06/2014
4	Pain (Aches) 12/2021 - 09/2015
2	Inflammation (Inflammations) 01/2021 - 01/2018
2	Hypersensitivity (Allergy) 09/2015 - 06/2014
1	Chronic Pain 01/2018
1	Acute Pain 09/2015
1	Painful Neuropathy 09/2015
1	Peripheral Nervous System Diseases (PNS Diseases) 09/2015
1	Neoplasms (Cancer) 09/2015
1	Peripheral Nerve Injuries 06/2014
1	Neuralgia (Stump Neuralgia) 06/2014

Drug/Important Bio-Agent (IBA)

4	N- (3- methoxyphenyl)- 4- chlorocinnamanilideIBA 01/2021 - 06/2014
2	TRPV1 receptorIBA 01/2021 - 06/2014
2	StaurosporineIBA 01/2021 - 01/2016
2	CarrageenanIBA 01/2021 - 01/2018
1	Opioid Analgesics (Opioids)IBA 12/2021
1	Opioid Receptors (Opioid Receptor)IBA 12/2021
1	Proteinase-Activated ReceptorsIBA 01/2021
1	2-furoyl-LIGRLO-amideIBA 01/2021
1	1,2- dioleoyl- sn- glycero- 3- phosphoethanolamine- N- arachidonoylIBA 01/2018
1	2- (2- chlorophenyl)- 3- (4- chlorophenyl)- 7- (2,2- difluoropropyl)- 6,7- dihydro- 2H- pyrazolo(3,4- f)(1,4)oxazepin- 8(5H)- oneIBA 01/2018
1	Ion Channels (Ion Channel)IBA 01/2018
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2018
1	EndocannabinoidsIBA 01/2018
1	seryl- leucyl- isoleucyl- glycyl- lysyl- valinamideIBA 01/2016
1	Peptides (Polypeptides)IBA 01/2016
1	Protein Kinases (Protein Kinase)IBA 01/2016
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2015
1	LigandsIBA 06/2014
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 06/2014

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 09/2015